Find the latest in EPAD news and research
-
Read more: Neurology
“Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without Dementia” Authors: Luigi Lorenzini, Alessio Maranzano, Silvia Ingala, Lyduine E. Collij, Mario Tranfa, Kaj…
All news and research
-
|
Expectations from new TDCs joining EPAD
-
|
Fundació ACE – Barcelona Alzheimer Treatment & Research Center, an entity devoted to the diagnosis, treatment, research and awareness on Alzheimer’s…
-
|
The European Prevention of Alzheimer’s Dementia initiative (EPAD) recruited its first Research Participant in May 2016 via the University of Edinburgh…
-
|
The 14th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 2019) and related neurological disorders took place in Lisbon (Portugal) from…
-
|
On 7 March, EPAD passes the mark of 1.500 research participants for its Longitudinal Cohort Study (LCS)! Congratulations to the Trial…
-
|
EPAD Goals 2019
-
|
2019 started with great intensity! On 5 February, EPAD held its PoC (Proof of Concept) Kick Off meeting in Berlin, Germany.…
-
|
On 4 February, over 90 representatives of the EPAD project met in Berlin. Participants included 15 dedicated teams from UK, Spain,…
-
|
What is your current role in EPAD? I am the resident Data Scientist based at the University of Edinburgh and I…
-
|
What is your current role in EPAD? I joined EPAD in October 2018 and am assigned as a lead EFPIA partner…
-
|
This month, we get to know the Grampian centre behind EPAD. The Grampian (that is in North East Scotland!) EPAD trial…
-
|
Alejandro Laquidain is one of the more than 200 Spanish research participants of the EPAD project recruited within the research center…
-
|
Another EPAD year has passed and we are proud to look back at a lot of successful deliveries and established relationships.…
-
|
The EPAD project aims to develop an environment for and then test multiple different interventions targeting the secondary prevention of…
-
European Prevention of Alzheimer’s DementiaLongitudinal Cohort Study (EPAD LCS): studyprotocol
-
Perspectives on Communicating Biomarker-BasedAssessments of Alzheimer’s Disease to CognitivelyHealthy Individuals
-
|
We are pleased to announce the arrival of a new project partner, MSD (Merck Sharp and Dohme). We say a warm…
-
|
The EPAD family of trial delivery centres grew to 20 sites in August 2018 with Brescia (Italy) enrolling its first research…
-
Ethical Arguments Concerning the Use of Alzheimer’s DiseaseBiomarkers in Individuals with No or Mild CognitiveImpairment: A Systematic Review and Framework forDiscussion
-
|
On 4 December, our partner Aridhia announced that its digital research platform AnalytiXagility used in the health, biomedical research and precision…
-
|
This month, we get to know the Tayside centre behind EPAD. The site began recruiting in February 2018, with its first…
No posts were found.
No posts were found.